Connect with us

Announcements

Founder of Israel’s “Tikun Olam” Affected by Medical Cannabis Scandal

Published

on

Founder of Israel’s “Tikun Olam” Affected by Medical Cannabis Scandal

Tikun Olam, which means “repair the world,” is described on its website as a “global medical cannabis brand operating in several countries around the world” and that it “cultivates, produces and provides evidence-based ward-winning medical cannabis.”

According to Calcalistech, an Israeli news source, regulatory reform instigated by the country’s Ministry of Health prevented the organization from supplying its patients with medical cannabis buds. The organization’s license was also placed on a temporary hold. Maayan Weisberg, foreign spokeswoman for Tikun Olam stated about the reform,

“Patients that need that certain type of treatment will go to different companies, because we didn’t have enough product to provide them, We are working as quickly as we can to get back to the production and up to regulation.”

The organization filed a petition with the court to reinstate its license, while the Israel Police recommended against reinstatement, arguing that there are compelling reasons about the company’s founder to prevent his participation in the medical cannabis business, reports Calcalistech.

The court ultimately ordered that the organization’s founder, Tzahi Cohen, to relinquish the majority of his organization’s shares, which comprise of his 70% stake. The shares will be placed in a blind trust. Cohen must also relinquish his role in the organization before its license is reinstated, but he can still profit from its operations. Tikun Olam unsuccessfully appealed. The court supported the ministry’s position that more research is needed before reinstating the organization’s license due to the potential risk to the public.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.